Mercer Global Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49.8M Sell
575,118
-5,725
-1% -$548K 0.07% 155
2025
Q4
$63.3M Buy
580,843
+38,926
+7% +$3.78M 0.1% 126
2025
Q3
$51.6M Buy
541,917
+126,172
+30% +$11.6M 0.09% 136
2025
Q2
$38.6M Buy
415,745
+42,433
+11% +$3.6M 0.08% 141
2025
Q1
$35.2M Buy
373,312
+96,031
+35% +$8.59M 0.08% 143
2024
Q4
$22.1M Sell
277,281
-11,472
-4% -$993K 0.05% 195
2024
Q3
$26.7M Buy
288,753
+159,197
+123% +$13.4M 0.06% 164
2024
Q2
$10.4M Buy
129,556
+561
+0.4% +$46K 0.03% 294
2024
Q1
$11.3M Buy
128,995
+20,932
+19% +$1.79M 0.03% 289
2023
Q4
$8.9M Sell
108,063
-15,086
-12% -$1.15M 0.03% 328
2023
Q3
$9.65M Sell
123,149
-37,849
-24% -$3.17M 0.04% 278
2023
Q2
$14.2M Buy
160,998
+21,818
+16% +$1.88M 0.06% 221
2023
Q1
$11.2M Buy
139,180
+17,242
+14% +$1.41M 0.05% 251
2022
Q4
$9.48M Buy
121,938
+6,894
+6% +$559K 0.05% 276
2022
Q3
$9.29M Buy
115,044
+5,094
+5% +$458K 0.06% 237
2022
Q2
$9.87M Buy
109,950
+2,057
+2% +$208K 0.06% 226
2022
Q1
$12M Buy
107,893
+10,438
+11% +$1.1M 0.07% 202
2021
Q4
$10.1M Buy
97,455
+3,691
+4% +$427K 0.06% 233
2021
Q3
$11.8M Sell
93,764
-665
-0.7% -$86.1K 0.08% 193
2021
Q2
$11.7M Sell
94,429
-473
-0.5% -$59.4K 0.09% 169
2021
Q1
$11.2M Buy
94,902
+3,898
+4% +$457K 0.1% 155
2020
Q4
$10.7M Sell
91,004
-52,254
-36% -$5.75M 0.13% 117
2020
Q3
$14.9M Sell
143,258
-6,952
-5% -$698K 0.22% 71
2020
Q2
$13.8M Buy
150,210
+15,163
+11% +$1.45M 0.25% 64
2020
Q1
$12.2M Buy
135,047
+37,575
+39% +$4M 0.27% 74
2019
Q4
$11.1M Buy
97,472
+5,858
+6% +$643K 0.22% 92
2019
Q3
$9.95M Buy
91,614
+13,651
+18% +$1.42M 0.23% 86
2019
Q2
$7.59M Buy
77,963
+8,263
+12% +$754K 0.2% 102
2019
Q1
$6.35M Buy
+69,700
New +$6.24M 0.23% 81

Other funds holding MDT

Mercer Global Advisors's MDT Position: Q1 2026 in Review

Mercer Global Advisors reduced its Medtronic (MDT) stake by 0.99% in Q1 2026, selling an estimated $548K and leaving 575,118 shares worth $49.8M. The position accounts for 0.07% of the portfolio, ranked #155.

Mercer Global Advisors first reported a position in MDT in Q1 2019 and has held it in 29 quarters since. The position peaked at $63.3M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Mercer Global Advisors held 575,118 shares of Medtronic worth $49.8M as of Q1 2026.
  • Mercer Global Advisors sold 5,725 Medtronic shares in Q1 2026, an estimated $548K.
  • Medtronic made up 0.07% of Mercer Global Advisors's portfolio in Q1 2026, its #155 holding.
  • Mercer Global Advisors first reported a position in Medtronic in Q1 2019 and has held it in 29 quarters since.
  • Mercer Global Advisors's Medtronic position peaked at $63.3M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.